Snijder B, et al. - Researchers searched for the clinical utility of image-based ex-vivo drug screening for patients with aggressive haematological malignancies. In an initial patient cohort, they identified that routine clinical integration of pharmacoscopy was technically feasible for treatment selection, and resulted in improved treatment.